The CIGB Biomedical Research Branch invites you to attend the 2nd Symposium
on Viral Hepatitis, which is going to be held from May 19th to May
After the successful experience with I and II Immunotherapy of Viral Hepatitis meetings
in 2005 and 2007 and the 1st Symposium
on Viral Hepatitis Varadero 2014, the 2nd Symposium on Viral Hepatitis Varadero
2016, is also being organized with a wide scope. This is the second of a bi-annual
series of meetings that aim to gather top international researchers focused on the
complete spectrum of Hepatitis B and C virus research, from viral pathogenesis to
immune therapy, including immune response evaluation, animal models and advances
in prophylactic and therapeutic vaccine development.
Special attention will be delivered to HeberNasvac, the First Therapeutic
Vaccine against Chronic Hepatitis B, which
got the Cuban Registration on December 2015. International partners for
Generium (Russia), Abivax (France), Xinkexian (China) will also attend the meeting.
The symposium also includes a space dedicated to HIV and other relevant virus co-infections
and a commercial fair organized by our sponsors. It is our intention to additionally
provide an adequate environment to promote scientific collaboration and interaction
between scientists attending this meeting.
Hepatitis 2016 will be held from May 19th to May 23rd 2016 at
Iberostar Laguna Azul
Hotel in Varadero, Cuba.